Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CPK | Common Stock | Sale | -$10.9K | -80 | -0.09% | $136.60 | 89.8K | Apr 1, 2022 | Direct | F1 |
transaction | CPK | Common Stock | Sale | -$188K | -1.36K | -1.51% | $138.72 | 88.4K | Apr 1, 2022 | Direct | F2 |
transaction | CPK | Common Stock | Sale | -$136K | -973 | -1.1% | $139.51 | 87.4K | Apr 1, 2022 | Direct | F3 |
transaction | CPK | Common Stock | Sale | -$12.8K | -91 | -0.1% | $140.35 | 87.4K | Apr 1, 2022 | Direct | F4, F5 |
Id | Content |
---|---|
F1 | The sale of shares on this Form 4 was effected pursuant to a Rule 10b 5-1 trading plan adopted by the reporting person on March 1, 2022. Broker open market sales of 80 shares on behalf of the reporting individual ranged from $136.59 to $136.610 in multiple transactions. Full information regarding the number of shares sold at each separate price will be provided upon request. |
F2 | The sale of shares on this Form 4 was effected pursuant to a Rule 10b 5-1 trading plan adopted by the reporting person on March 1, 2022. Broker open market sales of 1,356 shares on behalf of the reporting individual ranged from $138.07 to $139.03 in multiple transactions. Full information regarding the number of shares sold at each separate price will be provided upon request. |
F3 | The sale of shares on this Form 4 was effected pursuant to a Rule 10b 5-1 trading plan adopted by the reporting person on March 1, 2022. Broker open market sales of 973 shares on behalf of the reporting individual ranged from $139.095 to $139.99 in multiple transactions. Full information regarding the number of shares sold at each separate price will be provided upon request. |
F4 | The sale of shares on this Form 4 was effected pursuant to a Rule 10b 5-1 trading plan adopted by the reporting person on March 1, 2022. Broker open market sales of 91 shares on behalf of the reporting individual ranged from $140.23 to $140.56 in multiple transactions. Full information regarding the number of shares sold at each separate price will be provided upon request. |
F5 | Includes 3,235 deferred stock units, of which 28 were acquired for the reporting person since the last filing through reinvestment of dividends pursuant to a dividend reinvestment plan. Deferred stock units will be settled on a one-for-one basis in common stock. |